Secondly, regular assessments of inflammatory markers (e.g., CRP, IL-6) and metabolic parameters (e.g., blood glucose, lipid profiles) can provide insights into the progression of AAA and the effectiveness of intervention strategies. The gene discussed is IL6; the disease is triple-A syndrome.